IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET

Фармакоэкономика

N. Z. Musina¹  V. K. Fedyaeva²  V. A. Lemeshko² 

[1] Centre of Expertise and quality control of Russian Ministry of Health care;M. Sechenov First Moscow State Medical University, Ministry of Healthcare of the Russian Federation;

关键词: price regulation;    methods of pricing;    innovation index;    value-oriented pricing;   

DOI  :  10.17749/2070-4909.2017.10.4.025-030

来源: DOAJ

【 摘 要 】

The current approaches to the drug pricing commonly used worldwide allow for incorporating the therapeutic value of the drug into its consumer price. The drug pricing system existing in the Russian Federation restricts the availability of highly effective innovative drugs and leads to unnecessary expenses of the national budget. In this article, we propose a novel concept of price control relevant to Russia, which is based on the approaches used elsewhere.

【 授权许可】

Unknown